HR 7953In Committee
To accelerate patient access to innovative medicines and clinical trials for life-threatening diseases by establishing a reciprocal approval mechanism with trusted international regulatory authorities.
Introduced March 17, 2026
Summary
Timeline
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
See how this bill affects you
Enter your details to get a personalized impact estimate.
Check your impact